Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 124 publications
Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1: Update Alert 2).
Journal: Annals of internal medicine
Published: September 07, 2026
Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.
Journal: JAMA oncology
Published: May 31, 2026
The effectiveness and value of cytisinicline for smoking cessation: A summary from the institute for clinical and economic review's midwest comparative effectiveness public advisory council.
Journal: Journal of managed care & specialty pharmacy
Published: May 21, 2026
Risk Stratification for Breast Cancer Screening: AJR Expert Panel Narrative Review.
Journal: AJR. American journal of roentgenology
Published: May 06, 2026
Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 4).
Journal: Annals of internal medicine
Published: March 09, 2026
Incorporating Economic Evidence in Clinical Guidelines.
Journal: Annals of internal medicine
Published: February 16, 2026
The effectiveness and value of therapies for spinal muscular atrophy.
Journal: Journal of managed care & specialty pharmacy
Published: February 04, 2026
Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancers.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: December 23, 2025
Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.
Journal: JAMA
Published: December 12, 2025
Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial.
Journal: JAMA internal medicine
Published: December 12, 2025
Informing the US Medicare Drug Price Negotiation for Trelegy Ellipta and Breo Ellipta: Evaluating the Impact of Real-World Evidence.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 21, 2025
WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design.
Journal: Research square
Published: November 19, 2025
Last Updated: 09/26/2026